Psoriatic arthritis: Treat-to-target

Clinical and Experimental Rheumatology

Volumn 30, Issue 4 SUPPL.73, 2012, Pages

  Kavanaugh, A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Psoriatic arthritis; Treat to target

Indexed keywords

TUMOR NECROSIS FACTOR INHIBITOR;

ARTICLE; CLINICAL ASSESSMENT; DISEASE ACTIVITY; ECHOGRAPHY; HUMAN; NAIL DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; PATIENT MONITORING; POLYARTHRITIS; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; REMISSION; SCORING SYSTEM; SKIN DISEASE; SPINE DISEASE; VISUAL ANALOG SCALE;

ANTIRHEUMATIC AGENTS; ARTHRITIS, PSORIATIC; DISEASE MANAGEMENT; HUMANS; PATIENT CARE PLANNING;

EID: 84870285908     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. SMOLEN JS, ALETAHA D, BIJLSMA JW et al.: Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 2010;69:631-7.
2. COATES LC, FRANSEN J, HELLIWELL PS: Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment. Ann Rheum Dis 2010;69:48-53.
3. COATES LC, HELLIWELL PS: Validation of minimal disease activity criteria for psoriatic arthritis using interventional trial data. Arthritis Care Res (Hoboken) 2010;62:965-9.
4. KAVANAUGH A, FRANSEN J: Defining remission in psoriatic arthritis. Clin Exp Rheumatol 2006;24(Suppl. 43):S83-7.
5. KAVANAUGH A, RITCHLIN C: Systematic review of treatments for psoriatic arthritis: An evidenced based approach and basis for treatment guidelines. J Rheumatol 2006;33:1417-21.
6. RITCHLIN CT, KAVANAUGH A, GLADMAN dd et al.: and group for Research and ASSESSMENT OF PSORIASIS AND PSORIATIC ARTHRITIS (GRAPPA): Treatment recommendations for psoriatic arthritis. Ann Rheum Dis 2009;68:1387-94.
7. TORRE AJ, RODRIGUEZ PA, ARRIBAS CJ, BALLINA GJ, RIESTRA NJ, LOPEZ LC: Psoriatic arthritis (PA): a clinical, immunological and radiological study of 180 patients. Br J Rheumatol 1991;30:245-50.
8. MCHUGH NJ, BALAKRISHNAN C, JONES SM: Progression of peripheral joint disease in psoriatic arthritis. Rheumatology (Oxford) 2003;42:778-83.
9. SOKOLL KB, HELLIWELL PS: Comparison of disability and quality of life in rheumatoid and psoriatic arthritis. J Rheumatol 2001;28:1842-6.
10. HUSTED JA, GLADMAN DD, FAREWELL VT, COOK RJ: Health-related quality of life of patients with psoriatic arthritis: a comparison with patients with rheumatoid arthritis. Arthritis Rheum 2001;45:151-8.
11. KIM N, THRASH B, MENTER A: Comorbidities in psoriasis patients. Semin Cutan Med Surg 2010;29:10-5.
12. KAVANAUGH A: Guidelines for RA therapy - avoiding hamartia. Nat Rev Rheumatol 2010;6:505-6.
13. KERR EA, LUCATORTO MA, HOLLEMAN R, HOGAN MM, KLAMERUS ML, HOFER TP: Monitoring performance for blood pressure management among patients with diabetes mellitus; too much of a good thing? Arch Intern Med 2012;172:938-45.
14. WAKEFIELD RJ, D'AGOSTINO MA, NAREDO E et al.: After treat-to-target: can a targeted ultrasound improve RA outcomes? Ann Rheum Dis 2012;71:799-803.
15. FRAENKEL L, PETERS E, CHARPENTIER P, OLSE N, ERRANTE L, SCHOEN R, REYNA V: Decision tool to improve the quality of care in rheumatoid arthritis. Arthritis Care Res 2012;64:977-85.
16. ACKERMANN C, KAVANAUGH A: Economic burden of psoriatic arthritis. Pharmacoeconomics 2008;26:121-9. PMID: 18198932.